SCHEMBL8819680

SCHEMBL8819680

Nc1ncnc2c(C3=CCCC3)cn(-c3cccc(O)c3)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 11/20 0.36
EGFR P00533 7/20 0.36
ABL1 P00519 6/20 0.36
ABL2 P42684 6/20 0.36
CDK1 P06493 3/20 0.36
KDR P35968 4/20 0.36
RET P07949 2/20 0.36
FGFR1 P11362 2/20 0.36
JAK2 O60674 1/20 0.36
NTRK1 P04629 1/20 0.36
INSR P06213 1/20 0.36
LCK P06239 1/20 0.36
NPM1 P06748 1/20 0.36
CSF1R P07333 1/20 0.36
LYN P07948 1/20 0.36
IGF1R P08069 1/20 0.36
MET P08581 1/20 0.36
ROS1 P08922 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8819661 0.97 SRC (0.38) SRCEGFRABL1ABL2CDK1
SCHEMBL8819502 0.87 PI4KA (0.47) SRCEGFRABL1ABL2CDK1
SCHEMBL8820698 0.87 LIMK1 (0.37) SRCEGFRABL1ABL2CDK1
SCHEMBL8819671 0.87 EGFR (0.42) SRCEGFRABL1ABL2CDK1
SCHEMBL8819716 0.85 PI4KA (0.48) SRCEGFRABL1ABL2CDK1
SCHEMBL8820521 0.84 PI4KA (0.46) SRCEGFRABL1ABL2CDK1
SCHEMBL8819667 0.83 SRC (0.35) SRCEGFRABL1ABL2CDK1
SCHEMBL8819676 0.82 PI4KA (0.47) SRCEGFRABL1ABL2CDK1
SCHEMBL8819665 0.80 SRC (0.53) SRCEGFRABL1ABL2CDK1
SCHEMBL8819471 0.77 PI4KA (0.46) SRCEGFRABL1ABL2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997049706-A1 SUBSTITUTED 7-AMINO-PYRROLO[3,2-d]PYRIMIDINES AND THE USE THEREOF NOVARTIS AG (CH) 1997-12-31 WO claimed
WO-1997049706-A1 SUBSTITUTED 7-AMINO-PYRROLO[3,2-d]PYRIMIDINES AND THE USE THEREOF NOVARTIS AG (CH) 1997-12-31 WO disclosed